Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Affinity Biologicals

Affinity Biologicals
1987 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of products used worldwide in thrombosis and hemostasis research and medical diagnostics. The company's product line includes an extensive line of antibodies to coagulation and hemostasis related proteins, conjugates, antibody pairs for immunoassay of human and animal analytes, ELISA (enzyme-linked immunosorbent assay) kits, and a full line of human plasma products including immune-depleted plasmas, calibrators, and controls, along with services such as protein purification, antibody production, assay development, custom manufacturing, and lyophilization.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Parent Company
Precision BioLogic
Primary Office
  • 1348 Sandhill Drive
  • Ancaster, Ontario L9G 4V5
  • Canada

+1 (905) 000-0000

Affinity Biologicals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Affinity Biologicals‘s full profile, request access.

Request full access to PitchBook

Affinity Biologicals Executive Team (2)

Name Title Board
Seat
Contact
Info
Hugh Hoogendoorn Co Founder, President & Co-Owner
Patricia Hoogendoorn Co-Founder, Chief Financial Officer & Co-Owner